4/A

FORM 4/A SUBMISSION

Company: AMICUS THERAPEUTICS, INC.
Filed: June 17, 2020
Period of Report: June 27, 2019
Accession Number: 0001209191-20-037468

View Document ↗ View on SEC.gov ↗